Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.88 USD | -0.23% | -0.10% | -17.46% |
07:28pm | HSBC Upgrades Gilead Sciences to Hold From Reduce, Price Target is $69 | MT |
Apr. 23 | Argus Cuts Price Target on Gilead Sciences to $75 From $85 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.46% | 83.58B | |
+25.73% | 672B | |
+25.87% | 570B | |
-5.02% | 360B | |
+16.81% | 321B | |
+8.44% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.79% | 149B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences Unit Enters Into Licensing Agreement With Everest Medicines for Trodelvy